These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3449590)

  • 1. [Oral administration of OK-432 (Picibanil) (7th report). Clinical application: effects on advanced and recurrent cancers].
    Nio Y; Ohgaki K; Kan N; Tsuchitani T; Imai S; Okino T; Hori T; Tobe T; Nakamura M; Kodama H
    Nihon Gan Chiryo Gakkai Shi; 1987 Dec; 22(10):2436-45. PubMed ID: 3449590
    [No Abstract]   [Full Text] [Related]  

  • 2. [The oral administration of OK-432. The 5th report: the effects on the lymphoproliferative response and natural killer cell activity in mice with transplanted cecal tumors].
    Nio Y; Inamoto T; Hori T; Kan N; Tsuchitani T; Kodama H; Tobe T; Ohgaki K
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr; 20(3):597-608. PubMed ID: 4056544
    [No Abstract]   [Full Text] [Related]  

  • 3. [A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):997-1012. PubMed ID: 2202770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
    Nio Y; Ohgaki K; Henmi K; Kan N; Inamoto T; Tsuchitani T; Kodama H; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):728-34. PubMed ID: 6752308
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental study of oral administration of streptococcal preparation "OK-432". The 6th report: its effect on in vivo anti-tumor immunity of the mice with transplanted cecal tumor].
    Tsuchitani T; Kodama H; Tobe T; Nio Y; Kan N; Inamoto T; Ohgaki K
    Nihon Gan Chiryo Gakkai Shi; 1985 Apr; 20(3):609-17. PubMed ID: 2932509
    [No Abstract]   [Full Text] [Related]  

  • 6. [Investigation on the adequate administration interval with OK-432, using the cytotoxicity test].
    Tsukuda M; Furukawa S; Yoshida T; Yanoma S; Watanabe A; Takahashi K; Ono T; Sawaki S
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):423-5. PubMed ID: 2930206
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of endoscopical administration of OK-432 in 4 patients with advanced esophageal or gastric cancer].
    Satomi T; Inoue S; Fujita T; Ogawa S; Honda H; Hayashi M
    Gan No Rinsho; 1989 Mar; 35(4):512-5. PubMed ID: 2541269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):799-811. PubMed ID: 2196311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral administration of streptococcal preparation (OK-432) to advanced pancreatic cancer.
    Kodama M; Tanaka T
    Hiroshima J Med Sci; 1983 Jun; 32(2):167-71. PubMed ID: 6618899
    [No Abstract]   [Full Text] [Related]  

  • 10. [A controlled study of surgical adjuvant chemoimmunotherapy with FT-207 and OK-432 for advanced stomach cancer: the fourth study].
    Yamamura Y; Yasue M; Nakazato H; Ota K
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):541-8. PubMed ID: 3923941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the routes of administration of a streptococcal preparation, OK-432--with special reference to augmentation of the natural killer cell activity].
    Hosoi J; Wakasugi H; Miyata M; Minato N; Imai M
    Nihon Gan Chiryo Gakkai Shi; 1982 Dec; 17(8):2044-55. PubMed ID: 7169577
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combined treatment with radiotherapy and Streptococcus hemolyticus (OK-432) (author's transl)].
    Tsujii H; Mizoe J; Arimoto T
    Nihon Gan Chiryo Gakkai Shi; 1978 Oct; 13(5):560-6. PubMed ID: 722143
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
    Sakai Y; Maeda M; Koyama W; Totsuka S; Sakamoto S; Kanayama M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1978-80. PubMed ID: 3382244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytologic changes following intratumoral high dose injection of OK-432 in advanced pancreatic cancers and gall bladder cancers with ultrasound guidance].
    Okano Y; Takenaka A; Kasugai H; Morii T; Kishigami Y; Okuda S
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1892-3. PubMed ID: 6882009
    [No Abstract]   [Full Text] [Related]  

  • 15. [Administration of hemolytic streptococcus preparation OK-432 on recurrent gastric carcinoma].
    Hanaue H; Kurosawa T; Kitano Y; Miyagawa S; Nemoto A; Yamato H; Asagoe T; Shikata J
    Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1367-72. PubMed ID: 3501455
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of malignant ascites. I. Clinical studies on intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
    Katano M
    Fukuoka Igaku Zasshi; 1981 Oct; 72(10):532-42. PubMed ID: 7327498
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study on the effect of adjuvant immunochemotherapy using OK-432 and 5-FU in pharyngeal and laryngeal cancers].
    Yajin K; Harada Y; Tagashira N; Suzuki M; Hirakawa K; Sera K; Nakata M; Takebayashi S; Okazaki H; Yashiki T
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1921-7. PubMed ID: 3289502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical studies on the combined immunochemotherapy with a streptococcal preparation (Picibanil) and other anticancer drugs.
    Misawa S; Sawai K; Takino T; Masuda M; Abe T; Kawai K
    Nihon Gan Chiryo Gakkai Shi; 1979 Jun; 14(3):291-305. PubMed ID: 479655
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical investigation of intratumoral OK-432 administration].
    Shimada K; Tabuse K; Kono N; Katsumi M; Yamamoto H; Yamamoto Y; Endo A
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1844-9. PubMed ID: 6882008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of advanced cervical cancer with sequential administration of OK-432].
    Yakabe A; Sugino N; Yamashita S; Kinashi N; Ito T; Kamei T; Takasaki A
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1911-4. PubMed ID: 3209918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.